The polymorphic commensal fungus Candida albicans causes life-threatening disease via bloodstream and intra-abdominal infections in immunocompromised and transplant patients. Although host immune evasion is a common strategy used by successful human fungal pathogens, C. albicans provokes recognition by host immune cells less capable of destroying it. To accomplish this, C. albicans white cells secrete a low-molecular-weight chemoattractive stimulant(s) of macrophages, a phagocyte that they are able to survive within and eventually escape from. C. albicans opaque cells do not secrete this chemoattractive stimulant(s). We report here a physiological mechanism that contributes to the differences in the interaction of C. albicans white and opaque cells with macrophages. E,E-Farnesol, which is secreted by white cells only, is a potent stimulator of macrophage chemokinesis, whose activity is enhanced by yeast cell wall components and aromatic alcohols. E,E-farnesol results in up to an 8.5-fold increase in macrophage migration in vitro and promotes a 3-fold increase in the peritoneal infiltration of macrophages in vivo. Therefore, modulation of farnesol secretion to stimulate host immune recognition by macrophages may help explain why this commensal is such a successful pathogen.
C
andida albicans is a serious fungal pathogen for humans (1) . C. albicans is a dimorphic fungus and it has long been recognized that the ability to interconvert between the yeast and filamentous forms is essential for its pathogenicity. Thus, when we discovered that E,E-farnesol (referred to here as farnesol) is a quorum sensing molecule (QSM) for C. albicans which acts by blocking the conversion of yeasts to mycelia (2), we thought that farnesol would be an attractive lead compound in the design of novel antifungal drugs. However, this goal was not realized when we showed that farnesol itself acted as a virulence factor for C. albicans in a mouse intravenous infection model (3) . These observations presented a dilemma: how can farnesol act as a virulence factor when part of its mode of action is to block the yeast-mycelium morphogenesis, which is necessary for its pathogenicity? We resolve this conundrum here by showing that farnesol is also a potent stimulator of macrophage migration both in vitro and in vivo.
C. albicans is one of the best studied examples of an opportunistic fungal pathogen. It is a normal member of the human microbiota where it is found as a commensal primarily in the gastrointestinal and genitourinary tracts and on the skin of healthy individuals without causing significant disease. In healthy individuals, C. albicans commensals are controlled but tolerated while C. albicans pathogens are eliminated (reviewed in reference 4). The presence of innate immune phagocytes, which include both macrophages and neutrophils, is critical for early detection and elimination of C. albicans that have made the transition from commensal to an opportunistic pathogen (5-9; reviewed in reference 10). Thus, when normal immune responses are compromised, C. albicans can transition easily from a commensal to an opportunistic pathogen.
Another part of the transition from commensalism to pathogenicity is the ability of C. albicans strains that are homozygous at the mating type locus to reversibly convert between two distinct yeast phenotypes, the normal yeast morphology (white) and the mating competent elongated cell type (opaque [11] [12] [13] ). Approximately 3% of natural isolates are homozygous at the mating type locus (11) . The white and opaque morphologies of C. albicans are also specifically adapted to colonize distinct host niches; the opaque morphology is best adapted to colonize the skin commensally, whereas the white morphology is commonly associated with systemic infections. Critically, these two yeast morphologies also elicit different responses from host phagocytes, which may account for the partitioning of these morphologies during pathogenesis. First, opaque C. albicans only stimulates the random movement of polymorphonuclear leukocytes, including neutrophils, whereas the white phase secretes an unknown chemoattractant(s) that stimulates chemotactic migration directly toward the yeast cells (14) . Second, in a study comparing the engulfment of white and opaque cells by macrophages, it was found that a mouse macrophage cell line (RAW264.7 cells) and a Drosophila melanogaster hemocyte-derived cell line (S2) both engulfed white C. albicans much more effectively than they did opaque cells (15) . This difference is intriguing because engulfed white cells are able to survive within and then escape from macrophages in vitro (16) (17) (18) . This in vitro result is compatible with the importance of macrophages in vivo for the early elimination of C. albicans (19, 20) because macrophages which have engulfed C. albicans secrete immunoregulatory cytokines including interleukin-6 (IL-6), IL-1␤, IL-10, and tumor necrosis factor alpha (TNF-␣) (21) prior to the escape of C. albicans. These cytokines presumably promote the development and chemotactic migration of other innate immune cells, including neutrophils, which are more capable of killing C. albicans (22) . Even though evading host immunity is a common strategy used by pathogenic fungi (23) (24) (25) , we hypothesize C. albicans white cells produce a chemoattractive stimulant(s) that promotes their engulfment by macrophages. This may explain why C. albicans is so virulent in immunocompromised individuals, particularly those with neutropenia (1). One likely candidate for a phagocyte chemoattractive stimulant is the QSM farnesol. Farnesol is an appealing candidate because it is produced by white cells but not by opaque cells (26) , and it is already a known virulence factor for C. albicans (3) . Moreover, farnesol was previously found to activate neutrophils and stimulate proinflammatory cytokine production by monocytes, while dampening dendritic cell activity as antigen-presenting cells (21, 22) . We show here that the farnesol excreted by C. albicans stimulates macrophage migration by promoting chemokinesis rather than chemotaxis.
MATERIALS AND METHODS
accordance with institutional guidelines, and all efforts were made to minimize suffering of animals.
Primary mouse PEC preparation. Mouse peritoneal exudate cells (PECs) were elicited by intraperitoneal (i.p.) injection of 2 ml of thioglycolate broth. Four days later, the peritoneal cavities were flushed with 2 ml of DMEM, and the cells obtained were incubated at 10 6 cells/2 ml of DMEM cell culture medium (Invitrogen, Carlsbad, CA) containing 10% FBS (Invitrogen) and 50 g of gentamicin/ml (Invitrogen). These cells were used immediately in the mouse PEC chemotaxis assays.
Mouse macrophage chemotaxis assay. Primary C57BL/6 PECs and RAW264.7 cells were cultured as described above. The migration of both cell types was measured using the CytoSelect 96-well cell migration assay kit according to product specifications (Cell Biolabs, San Diego, CA). Briefly, aliquots of 10 6 cells in culture media were placed into the top chamber of a 5-m-pore-size polycarbonate membrane transwell plate. Chemoattractant solutions were placed in the bottom chamber. Cells were incubated with each chemoattractant solution for 2 h, at which time the migratory cells were harvested, lysed, and measured by the fluorescence of macrophage nuclei normalized to a control of culture medium without macrophages (normalized RFU). Farnesol was added from a 100 mM stock in methanol prepared fresh each use. Stock solutions of zymosan A (25 mg/ml in PBS) and aromatic alcohols (100 mM in methanol) were also diluted into DMEM, and 1% methanol in DMEM was used as a negative control, whereas 50 ng of monocyte chemotactic protein 1 (MCP-1)/ml in DMEM was used as a positive control.
To test the migratory potential of macrophages toward C. albicanssecreted QSMs, supernatants were harvested from early stationary-phase C. albicans cultures grown in 25 ml of SC or GPP medium at 30°C with 225-rpm aeration. The supernatants were passed twice through a 20-mpore-size nitrate cellulose filter to ensure all C. albicans cells were removed prior to the addition of 40 to 120 l of DMEM in the bottom chamber of the transwell plate.
To test whether farnesol stimulates chemotaxis or chemokinesis, the migration of RAW 264.7 cells was measured using the Neuro Probe ChemoTx system according to product specifications using a checkerboard assay (Neuro Probe, Gaithersburg, MD). Briefly, the bottom wells of the NeuroProbe ChemoTx System chamber were filled with ϳ300 l of medium containing or lacking farnesol. Then, 40 l of 10 6 RAW 264.7 cells/ml suspended in culture medium (DMEM ϩ 0.5% FBS) containing or lacking farnesol was placed on top of a 5-m-pore-size polycarbonate membrane filter. The ChemoTx System was incubated at 37°C and 5% CO 2 for 6 h. After incubation, nonmigratory cells were removed from the filter surface, and adherent cells that migrated through the filter were detached through addition of 2.5 mM EDTA-PBS to the top of the filter and allowed to incubate for 30 min at room temperature, followed by centrifugation of the plate at 1,400 rpm for 5 min. Migratory cells were examined microscopically and five fields of cells (from a total well area of 25.5 mm 2 ) were counted per well with five replicate wells per treatment. Mice and in vivo chemotaxis assay. As described by Navarathna et al. (3) , commercial E,E-farnesol (Sigma-Aldrich, St. Louis, MO) was diluted in 0.5% (vol/vol) Tween 80 (Sigma-Aldrich) in sterile, nonpyrogenic PBS. Mice were injected i.p. with 1 ml of fresh 20 mM (4.4 mg) E,E-farnesol dissolved in 0.5% Tween 80, aged thioglycolate broth, or 0.5% Tween 80. Three days later, the peritoneal cavities were flushed with 2 ml of DMEM, and the PECs were counted. To assay for macrophage populations within the peritoneum, the PECs were stained with peridinin chlorophyll protein-labeled anti-CD11c and fluorescein isothiocyanate-labeled anti-CD11b in the presence of Fc Block (2.4G2; all antibodies were purchased from eBiosciences, San Diego, CA). After surface staining, the cells were fixed in 1% paraformaldehyde and analyzed using a Becton Dickinson FACSCalibur, and the data were processed using FlowJo software (Tree Star, San Carlos, CA).
Statistical analysis. A Student two-tailed unpaired t test was used to determine the significance of differences between means for transwell chemotaxis experiments with relative fluorescence measurements of migration (*, P Ͻ 0.05; **, P Ͻ 0.001). The GLIMMIX procedure in SAS (SAS Institute, Inc., Cary, NC) was used to determine the treatment least-squares means for transwell chemotaxis experiments with cells/field counts (*, P Ͻ 0.05; **, P Ͻ 0.001). The cutoff for statistical significance was set at a P value of Ͻ0.05. Statistical analyses were performed using GraphPad Prism 5.0 (GraphPad Software, San Diego, CA) for transwell chemotaxis experiments with relative fluorescence measurements of migration, and using SAS for the transwell chemotaxis experiment with cells/field counts.
RESULTS
Macrophages preferentially migrate toward supernatants of C. albicans white cells. White-cell supernatants of C. albicans, but not opaque-cell supernatants, stimulate chemotaxis of neutrophils (14) . Since macrophages interact differently with opaque cells compared to white cells (15, 20) , we hypothesized that, like neutrophils, macrophages might display differential migration patterns toward white and opaque C. albicans. We first sought to determine whether C. albicans white-cell supernatants preferentially stimulate macrophage migration relative to the opaque-cell supernatants as assayed by a transwell cell migration (Fig. 1A) . Briefly, 10 6 serum-starved RAW 264.7 cells were incubated in cell culture medium (i.e., DMEM), while separated from possible che- moattractants in the respective supernatants by a permeable membrane with a 5-m-pore-size cutoff. Macrophages attracted to potential chemoattractants distend their pseudopodia and migrate through the membrane toward the chemoattractant. After 2 h, macrophage migration into the lower chamber was quantified by fluorescently staining the macrophage nuclei. Separate cohorts of RAW 264.7 cells were incubated with uninoculated macrophage cell culture medium or with MCP-1 (30, 31) as negative and positive controls, respectively (Fig. 1A) . Significantly, supernatants from two C. albicans strains, SC5314 and WO-1, stimulated ϳ3-fold more RAW 264.7 cell migration than did 250 ng of MCP-1/ml. In addition, the supernatants from WO-1 white cells stimulated 2.3-fold-greater migration than the supernatants from WO-1 opaque cells (Fig. 1A) . WO-1 opaque-cell supernatants and MCP-1 stimulated similar amounts of RAW 264.7 cell migration. Thus, SC5314 and WO-1 white-cell supernatants contain secreted molecules that stimulate significantly more macrophage migration than supernatants from opaque cells even though these strains differ at their MTL locus because SC5314 is heterozygous for the MTLa and MTL␣ alleles, whereas WO-1 is homozygous for the MTL␣ allele (11) .
The fungal quorum sensing molecule farnesol stimulates the migration of macrophage in vitro. Farnesol is produced naturally by both C. albicans SC5314 and WO-1 white cells at concentrations of 2 to 100 M (32) but not by opaque cells (26) , and thus it is a candidate for the white-cell factor that stimulates positive migration of macrophages. We tested the ability of farnesol to promote migration of both RAW 264.7 cells (Fig. 1C) and primary peritoneal exudate cells (PECs) containing 90% inflammatory macrophages (Fig. 1D) . Biologically relevant concentrations of farnesol (2 to 60 M) were sufficient to promote increases in the migration of RAW 264.7 cells and PECs in a dose-dependent manner up to concentrations of farnesol that are toxic for macrophages in cell culture (80 to 100 M) (Fig. 1C and D and data not shown). Farnesol stimulated up to 8.5-and 5-fold more RAW 264.7 and PEC migration, respectively. Methanol at 0.1%, a vehicle control, did not promote migration of either RAW 264.7 cells or PECs (data not shown). Moreover, the addition of biologically relevant concentrations of farnesol (Ն20 M) added to opaque supernatants was sufficient to stimulate an increase in the migration of RAW 264.7 cells to the same level, as was seen with whitecell supernatants (Fig. 1B) , whereas Յ20 M farnesol did not. Together, these data suggest that farnesol secreted by C. albicans white cells promotes the migration of macrophages.
Farnesol stimulates chemokinesis of macrophages in vitro. Neutrophils respond to C. albicans white-cell supernatants by positive chemotaxis and opaque-cell supernatants by chemokinesis (14) . Chemotaxis is directed movement up a chemical concentration gradient, whereas chemokinesis is gradient-independent activation of movement in response to a chemical stimulus. To determine whether the observed induction of migration of RAW 264.7 cells in response to farnesol was due to chemotaxis or chemokinesis, RAW 264.7 cell migration was evaluated in a transwell checkerboard migration assay with 20 M farnesol in the lower well (Ϫ/FOH), the upper well (FOH/Ϫ), or both wells (FOH/FOH; Fig. 1E ). As before, the RAW 264.7 cells were added to the top well and detected in the bottom well. Consistently, farnesol in the lower well led to macrophage migration from the upper to the lower transwell. Significantly, farnesol added to the upper well also enhanced the migration of macrophages regardless of whether farnesol was present in the lower well (Fig. 1E) ; a chemical gradient of farnesol was not necessary. These data suggest that farnesol acts as a stimulant for chemokinesis, not chemotaxis.
For neutrophils, Geiger et al. (14) showed that the chemoattractants released by C. albicans included at least two components responsible for chemokinesis and chemotaxis. These authors further showed that chemokinesis and chemotaxis were separable and that one of the components necessary for chemotaxis was a peptide of ϳ1,000 Da because boiling and treatment with proteinase K removed the chemotactic but not the chemokinetic activity. We have now demonstrated, at least for macrophages, that the component responsible for chemokinesis is likely farnesol. Thus, the two activities can be readily distinguished on the basis of the chemical and physical properties of their active components. As we showed when we first identified farnesol as a quorum sensing molecule (2), farnesol (222 Da) is lipid soluble, extractable into ethyl acetate or hexane, stable at 100°C for 30 min, and insensitive to trypsin, pronase, thermolysin, and proteinase K. However, it is still unclear whether cell chemotaxis requires a combination of farnesol and the 1-kDa peptide or whether the peptide by itself is sufficient.
Aromatic alcohols and cell wall components enhance macrophage migration in response to farnesol. In the context of C. albicans interactions with the human host, the innate immune system encounters farnesol as part of a complex mixture of immunostimulatory and immunosuppressive signals. C. albicans immunomodulatory signals come in the form of cellular debris from dead and dying cells, as well as from excreted metabolic products. Two possible immunomodulatory signals common to both the white and opaque morphologies of C. albicans are fungal cell wall carbohydrates and the aromatic alcohols tyrosol, tryptophol, and phenethyl alcohol (21, (33) (34) (35) . Thus, these immunomodulatory signals were tested for their chemotactic potential both on their own and in combination with farnesol. Zymosan A, a proteincarbohydrate complex prepared from yeast cell walls, stimulates macrophage to express both inflammatory and regulatory cytokines as mediated through a Toll-like receptor 2 (TLR2) and Dectin-1 response (21, 36, 37) . We therefore sought to determine whether zymosan A could stimulate mouse macrophage migration on its own or enhance the migration-stimulating activity of farnesol. Zymosan A (25 g/ml) alone does not stimulate movement of RAW 264.7 cells (Fig. 2A) or primary PECs (Fig. 2B) , and it did not enhance macrophage movement due to farnesol (Fig.  2A) . These data suggest that even though zymosan A stimulates the expression of both inflammatory and regulatory cytokines, it does not stimulate macrophage chemotaxis or chemokinesis due to farnesol.
Secretion of the aromatic alcohols (tyrosol, phenethyl alcohol, and tryptophol) influences growth, morphogenesis, and biofilm formation by C. albicans (reviewed in reference 38), but their role in the innate immune response to C. albicans is currently unknown. Biologically relevant concentrations of aromatic alcohols did not stimulate the migration of mouse macrophages ( Fig. 2A) or primary PECs (Fig. 2B) , a finding that is consistent with the observation that white and opaque cells both secrete significant levels of these aromatic alcohols (Table 1) . However, their combinatorial chemotactic potential was evident in that the combination of aromatic alcohols and farnesol stimulated RAW 264.7 cell migration 1.6-fold better than did farnesol alone ( Fig. 2A) , and the combinations of all three signals (zymosan A, aromatic alcohols, and farnesol) were 2.0-and 1.3-fold better than farnesol alone or in combination with the aromatic alcohols, respectively ( Fig. 2A) . In summary, our results show that zymosan A and the aromatic alcohols do not stimulate the migration of phagocytes on their own, but they do enhance the migration stimulated by farnesol.
Farnesol stimulates the migration of macrophages into the peritoneum in vivo. The results thus far demonstrate that farnesol has chemokinetic activity toward macrophages in vitro. Therefore, we wondered whether farnesol also elicits macrophage migration in vivo. Accordingly, B10.s mice were injected i.p. with 1 ml of 20 mM farnesol in 0.5% Tween 80-PBS and 3 days later PECs were collected and analyzed by flow cytometry (Fig. 3A, middle) . This farnesol concentration and delivery vehicle were chosen to replicate our previous work in a mouse model of systemic candidiasis, which showed that farnesol is a virulence factor (3). Separate cohorts of mice were injected with either 1 ml of 0.5% Tween 80-PBS or 2 ml of sterile thioglycolate broth to serve as negative and positive controls, respectively (Fig. 3A, left and right) . Macrophages and dendritic cells in the PEC populations were quantified by staining with fluorescent antibodies to CD11b and CD11c (Fig. 3) . Mice injected with farnesol had a nearly 3-fold increase in the percentage of PECs that were CD11b hi cells (indicative of macrophages) compared to Tween 80-PBS alone (Fig. 3B) . This increase with farnesol was ϳ1.6-fold greater than that which occurred with the thioglycolate positive control (Fig. 3B) . In addition, the absolute number of CD11b hi cells recovered from the PECs of farnesol-treated mice was 60-fold greater than that with Tween 80-PBS alone (Fig. 3C) .
In contrast to farnesol stimulating macrophage influx into the peritonea of mice, mice injected with the vehicle control had a 1.5-fold increase in the percentage of CD11c hi /CD11b lo PECs (indicative of dendritic cells) compared to farnesol (Fig. 3D ). This decrease in farnesol recruitment of dendritic cells was also seen relative to thioglycolate-injected mice. Thioglycolate-treated mice showed an ϳ4.5-fold greater percentage of CD11c hi /CD11b lo PECs than the farnesol-treated mice (Fig. 3D ) and a nearly 6-fold increase in the absolute number of CD11c hi /CD11b lo cells in the peritoneum compared to farnesol-treated mice (Fig. 3E) . Therefore, farnesol is a significant stimulator of macrophage migration, but not dendritic cell migration in vivo.
DISCUSSION
In this study, we show that farnesol, which is secreted by C. albicans white cells, but not by opaque cells (26) , modulates innate immune responses by directly stimulating movement of macrophages thus explaining the greater engulfment of white cells as observed by Lohse and Johnson (15) . These results suggest that production of farnesol by C. albicans white cells contributes to virulence by stimulating macrophages. In contrast, the lack of farnesol production by opaque-phase cells leads to less macrophage stimulation and attenuated virulence. These results are also consistent with the differences in virulence seen for C. albicans cells that produce different levels of farnesol. For example, C. albicans pretreated with subinhibitory levels of fluconazole produced up to 12-fold more farnesol and were up to 8.5-fold more lethal (39), while C. albicans cells lacking DPP3 produced 6-fold Zymosan A (25 mg/ml) in PBS and 100 mM aromatic alcohols in methanol (prepared fresh for each use) were diluted into DMEM. Then, 1% methanol in DMEM was used as a negative control. Although methanol is toxic to macrophages, the macrophages and C57BL/6 PECs remained viable in up to 1% methanol during the time frame of this experiment. Graphs show the means Ϯ the SEM for at least four replicate wells and are representative of three independent experiments (*, P Ͻ 0.05; **, P Ͻ 0.001).
less farnesol and were 4.2-fold less pathogenic (3) . Further, C. albicans ATCC 10231, a natural strain that produces farnesoic acid, but not farnesol is 10-fold less pathogenic (3). These results are significant because the ineffectiveness of macrophages in killing phagocytosed C. albicans helps to explain why farnesol is a virulence factor even though in vitro it also prevents yeast-filament morphogenesis, an important virulence trait. Our observation that farnesol stimulates macrophages to migrate is consistent with work showing that farnesol affects aspects of host immune responses differently (21, 22) . Recently, Leonhardt et al. (22) showed that neutrophils, which are more capable of killing C. albicans (19, 20) , are only weakly stimulated by farnesol at physiologically relevant concentrations (50 to 100 M). Similarly, monocytes are stimulated by farnesol to produce proinflammatory cytokines (21, 22) . In contrast, the differentiation of monocytes into dendritic cells and their subsequent migrational behavior are impaired by farnesol (22) . Taken together, these observations suggest in part that farnesol acts as a virulence factor by dampening the adaptive immune response while stimulating the innate immune response. This distinction is important for two reasons. First, we and others have shown that C. albicans cells that are phagocytosed by macrophages respond by forming hyphae that penetrate the macrophage plasma membrane, thus killing the macrophages 3 to 6 h after ingestion and thereby permitting their escape (16) (17) (18) . Significantly, this escape may occur at a location in the host far distant from where the C. albicans was phagocytosed. Second, suppression of the dendritic cell activity with regard to antigen presentation to T cells of the adaptive arm of the immune system suggests that the host can only develop an inefficient adaptive response to Candida. Thus, farnesol can modulate the host immune response to favor its survival and dissemination within its host.
We speculate that C. albicans, through control of the whiteopaque switch, evolved to stimulate macrophages for dissemination through the host. This idea suggests that the first step in the "Trojan horse strategy" for dissemination of some bacterial and viral pathogens (40, 41) is also used by C. albicans (19, 42) . In terms of the overall balance between host and pathogen, it is highly relevant that prior to their death, macrophages that ingest C. albicans secrete immunoregulatory cytokines, including IL-6, IL-1␤, IL-10, and TNF-␣ (21), presumably in order to promote the development and chemotactic migration of other, more capable members of the innate immune system, such as neutrophils (19, 20) . This idea is consistent with the importance of macrophages in early elimination of C. albicans (43, 44) , as well as the predisposition to invasive candidiasis of patients with neutropenia (1). We have not yet determined whether farnesol is a chemoattractive stimulant for neutrophils to the same degree as it is for macrophages.
The roles of phagocytic cells in controlling candidiasis in healthy and immunocompromised individuals are not well understood. However, information about small signaling molecules, such as farnesol, possibly secreted by the gut microbiota may be helpful to tease apart these differences. In immunocompromised hosts secretion of farnesol may promote C. albicans dissemination through macrophages as described above. This model could explain in part the high level (70%) of systemic candidiasis in immunodeficient small bowel transplant recipients (45, 46) . This scenario is potentially even more profound in patients with neutropenia treated with classes of antifungal drugs that enhance the production of farnesol by C. albicans (47) (48) (49) . In contrast, in immunocompetent hosts, farnesol detection may serve a critical surveillance function for the phagocytes in controlling fungal dissemination. Thus, through the modulation of QSM expression, C. albicans has the potential to directly control its fate within the host.
